1. Home
  2. AMCX vs EBS Comparison

AMCX vs EBS Comparison

Compare AMCX & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMC Networks Inc.

AMCX

AMC Networks Inc.

HOLD

Current Price

$9.79

Market Cap

411.2M

ML Signal

HOLD

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

HOLD

Current Price

$7.26

Market Cap

413.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMCX
EBS
Founded
1980
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Cable & Other Pay Television Services
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
411.2M
413.3M
IPO Year
2011
2006

Fundamental Metrics

Financial Performance
Metric
AMCX
EBS
Price
$9.79
$7.26
Analyst Decision
Sell
Strong Buy
Analyst Count
4
1
Target Price
$7.33
$12.00
AVG Volume (30 Days)
469.7K
772.3K
Earning Date
05-08-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
132.55
125.83
EPS
N/A
0.07
Revenue
$2,311,801,000.00
$742,900,000.00
Revenue This Year
N/A
$1.29
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$107.14
Revenue Growth
N/A
N/A
52 Week Low
$5.41
$5.62
52 Week High
$11.13
$14.06

Technical Indicators

Market Signals
Indicator
AMCX
EBS
Relative Strength Index (RSI) 50.50 36.25
Support Level $9.31 N/A
Resistance Level $10.38 $8.59
Average True Range (ATR) 0.47 0.28
MACD -0.06 -0.06
Stochastic Oscillator 33.95 2.09

Price Performance

Historical Comparison
AMCX
EBS

About AMCX AMC Networks Inc.

AMC Global Media owns several linear TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network,reached 55 million pay TV households in the US at the end of 2025. The firm also had nearly 10.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: